Patrick Mismetti

11.8k total citations · 3 hit papers
118 papers, 6.8k citations indexed

About

Patrick Mismetti is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Patrick Mismetti has authored 118 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Internal Medicine, 69 papers in Cardiology and Cardiovascular Medicine and 34 papers in Surgery. Recurrent topics in Patrick Mismetti's work include Venous Thromboembolism Diagnosis and Management (80 papers), Atrial Fibrillation Management and Outcomes (54 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (14 papers). Patrick Mismetti is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (80 papers), Atrial Fibrillation Management and Outcomes (54 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (14 papers). Patrick Mismetti collaborates with scholars based in France, United States and United Kingdom. Patrick Mismetti's co-authors include Clive Kearon, Sam Schulman, Ajay K. Kakkar, Samuel Z. Goldhaber, Henry Eriksson, Sebastian Schellong, David Baanstra, Silvy Laporte, Janet Schnee and Jeffrey Friedman and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Patrick Mismetti

114 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

2009 1.9k citations Sam Schulman, Ajay K. Kakkar et al. profile →
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

2013 713 citations Sam Schulman, Ajay K. Kakkar et al. profile →
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

2013 688 citations Sam Schulman, Ajay K. Kakkar et al. profile →

Peers

Countries citing papers authored by Patrick Mismetti

Since Specialization

Citations

This map shows the geographic impact of Patrick Mismetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Mismetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Mismetti more than expected).

Fields of papers citing papers by Patrick Mismetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Mismetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Mismetti. The network helps show where Patrick Mismetti may publish in the future.

Co-authorship network of co-authors of Patrick Mismetti

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Mismetti. A scholar is included among the top collaborators of Patrick Mismetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Mismetti. Patrick Mismetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The management of acute venous thromboembolism in clinical practice 2017 ·Thrombosis and Haemostasis ·Alexander T. Cohen, Anselm K. Gitt, Rupert Bauersachs, Eva‐Maria Fronk, Petra Laeis, Patrick Mismetti, Manuel Monréal, Stefan N. Willich, Peter Bramlage, Giancarlo Agnelli, (unknown)	66
2	Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015 2016 ·Anaesthesia Critical Care & Pain Medicine ·Pierre Albaladejo, Fanny Bonhomme, Normand Blais, Jean‐Philippe Collet, David Faraoni, Pierre Fontana, Anne Godiér, Juan V. Llau, Dan Longrois, Emmanuel Marret, Patrick Mismetti, Nadia Rosencher, Stéphanie Roullet, Charles Marc Samama, Jean‐François Schved, Piérre Siè, A. Steib, Sophie Susen	53
3	Treatment Satisfaction In Patients With Venous Thromboembolism As Measured With Pact-Q2: Prefer In Vte Registry 2014 ·Value in Health ·SN Willich, Rupert Bauersachs, Anselm K. Gitt, Patrick Mismetti, (unknown), (unknown), Giancarlo Agnelli, Alexander T. Cohen	2
4	Readmittance To Hospital Within 6 Months After A Venous Thromboembolism Event: Prefer In Vte Registry 2014 ·Value in Health ·Rupert Bauersachs, (unknown), Patrick Mismetti, (unknown), SN Willich, (unknown), Giancarlo Agnelli, A. Cohen	1
5	Health State In Patients With Venous Thromboembolism On Conventional And Non-Vka Oral Anticoagulants As Assessed With The Eq-5d-5l Questionnaire: Prefer In Vte Registry 2014 ·Value in Health ·A. Cohen, Rupert Bauersachs, Anselm K. Gitt, Patrick Mismetti, (unknown), SN Willich, (unknown), Giancarlo Agnelli	4
6	Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery 2013 ·Annals of Surgery ·Ajay K. Kakkar, Giancarlo Agnelli, Winfield S. Fisher, Daniel J. George, Michael R. Lassen, Patrick Mismetti, Patrick Mouret, Judith H. Murphy, Francesca Lawson, Alexander G.G. Turpie	28
7	Intoxications graves au méprobamate : description d’une série de 146 cas dans le département de la Loire 2012 ·Therapies ·(unknown), Bertrand Pons, Xavier Delavenne, Marie‐Noëlle Beyens, (unknown), Fabrice Zéni, Patrick Mismetti, Thierry Basset	4
8	Nouveaux anticoagulants par voie orale : quelle place pour les analyses de biologie médicale ? 2011 ·Sang thrombose vaisseaux ·Isabelle Gouin‐Thibault, Patrick Mismetti, Claire Flaujac, Xavier Delavenne, Silvy Laporte, Marie‐Anne Loriot, Thomas Lecompte	5
9	Traitement anticoagulant initial de l’embolie pulmonaire 2011 ·Revue des Maladies Respiratoires ·Laurent Bertoletti, Patrick Mismetti	2
10	Individual patient data meta‐analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients 2011 ·Journal of Thrombosis and Haemostasis ·Silvy Laporte, J. Liotier, Laurent Bertoletti, F. X. Kleber, (unknown), Céline Chapelle, (unknown), Patrick Mismetti	30
11	AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging study 2009 ·Journal of Thrombosis and Haemostasis ·Michael R. Lassen, O.E. Dahl, Patrick Mismetti, (unknown), Alexander G.G. Turpie	38
12	Recommendations on biosimilar low‐molecular‐weight heparins 2009 ·Journal of Thrombosis and Haemostasis ·Job Harenberg, A. K. Kakkar, D. BERGQVIST, T W Barrowcliffe, Benito Casu, Jawed Fareed, Patrick Mismetti, Frederick A. Ofosu, (unknown), M Samama, Sam Schulman	26
13	Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: A prospective cohort of 2736 women 2008 ·Thrombosis Research ·Céline Chauleur, Sara Quenet, Marie-Noëlle Varlet, P. Seffert, Silvy Laporte, Hervé Decousus, Patrick Mismetti	24
14	Clinical Predictors for Fatal Pulmonary Embolism in 15,520 Patients with Venous Thromboembolism: Findings from the Registro Informatizado de la Enfermedad Thrombo Embolica Venosa (RIETE) Registry 2008 ·Journal of Vascular Surgery ·Silvy Laporte, Patrick Mismetti, Hervé Decousus	3
15	Méthodologie des essais cliniques : pourquoi et pour qui ? Les notions essentielles à une lecture critique 2007 ·Patrick Mismetti, Silvy Laporte	0
16	Anti‐factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old 2007 ·British Journal of Clinical Pharmacology ·Aliénor Berges, Silvy Laporte, Magali Epinat, Paul Zufferey, É. Alamartine, Brigitte Tranchand, Hervé Decousus, Patrick Mismetti, (unknown)	24
17	Optimal low-molecular-weight heparin regimen in major orthopaedic surgery 2003 ·Thrombosis and Haemostasis ·Silvy Laporte, Sara Quenet, Serge Molliex, C. Auboyer, (unknown), Patrick Mismetti, Paul Zufferey	21
18	Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: an individual mathematical model 2002 ·Blood Coagulation & Fibrinolysis ·B. Charpiat, (unknown), Patrick Mismetti, (unknown), Christian Ducerf	6
19	Pharmacokinetic and pharmacodynamic variations of acenocoumarol orally administrated either once or twice daily in patients with deep venous thrombosis 1998 ·Fundamental and Clinical Pharmacology ·Patrick Mismetti, J. Reynaud, S Laporte‐Simitsidis, H.H.W. Thijssen, B. Tardy-Poncet, Bernard Tardy, Andréa Buchmuller, H Decousus	5
20	INFLUENCE OF CONFOUNDING FACTORS ON DESIGNS FOR DOSE–EFFECT RELATIONSHIP ESTIMATES 1995 ·Statistics in Medicine ·Pascal Girard, S Laporte‐Simitsidis, Patrick Mismetti, Hervé Decousus, Jean‐Pierre Boissel	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact